Freedom Leaf, Inc. Developing Lady Cannabis Hemp CBD Skin Care Line

LAS VEGAS, NV--(Marketwired - Aug 24, 2016) - Freedom Leaf, Inc. (OTC PINK: FRLF)

• Lady Cannabis™ Divinely Designed Hemp Inspired™ is a unique High CBD extract
• Product 100% grown in the USA
• Skin care line derived from Mother Nature

Freedom Leaf, Inc. (OTC PINK: FRLF) said it's developing Lady Cannabis™ as one of the first beauty product lines offering 100% grown-in-the USA Hemp High Cannabidiol, CBD.

Lady Cannabis™ Divinely Designed Hemp Inspired™ will sell a unique, premium High CBD extract to promote health, beauty and well-being.

"The name, Lady Cannabis was conceived for plant-based products from Mother Nature," said Freedom Leaf, Inc. CEO, Cliff Perry. "Freedom Leaf CBD-infused products will be manufactured under strict certified production laboratory facilities labeled with batch, lot number and expiration controls."

This approach will give the Lady Cannabis™ product line a strong competitive advantage as it reaches out directly to consumers through LadyCannabis.com and word of mouth sales.

Freedom Leaf, Inc. named product development and branding expert Charles Mui as vice president of sales and marketing to leverage the benefits of Lady Cannabis™ Divinely Designed Hemp Inspired™ through an affiliate marketing effort.

"The largest growth category within the skin care market is anti-aging," Mui said. "Now, more than ever, consumers are becoming more aware of what they put in, and on, their bodies to stay healthy."

Freedom Leaf has been positioning itself for direct to customer sales by growing its consumer data and online digital media and publishing network. The Lady Cannabis product line is expected to launch in time for Christmas, Hanukkah, Kwanzaa, Holiday season 2016.

Most of the HEMP CBD used within topical products is imported from overseas, which tends to have very low testing results and contaminants.

The USA grown High CBD that Freedom Leaf has identified for its Lady Cannabis™ line is required to go through the highest levels of testing for a nutraceutical ingredient.

Cannabidiol (CBD) is a legal compound in the hemp plant that has shown to offer beneficial medical effects including antioxidant and anti-inflammatory properties to the body without the psychoactive effects associated with Tetrahydrocannabinol (THC).

Scientific and clinical research, much of it sponsored by the U.S. government, underscores CBD's potential as a treatment for a wide range of conditions, including arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, paranoia and other neurological disorders. CBD has demonstrable neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and around the world.